These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 7582489
1. Elevation of plasma noradrenaline levels in urethane-anaesthetized rats by activation of central prostanoid EP3 receptors. Yokotani K, Nishihara M, Murakami Y, Hasegawa T, Okuma Y, Osumi Y. Br J Pharmacol; 1995 Jun; 115(4):672-6. PubMed ID: 7582489 [Abstract] [Full Text] [Related]
2. Inhibition of vagally mediated gastric acid secretion by activation of central prostanoid EP3 receptors in urethane-anaesthetized rats. Yokotani K, Okuma Y, Osumi Y. Br J Pharmacol; 1996 Feb; 117(4):653-6. PubMed ID: 8646410 [Abstract] [Full Text] [Related]
3. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat. Shimizu T, Tanaka K, Nakamura K, Taniuchi K, Yawata T, Higashi Y, Ueba T, Dimitriadis F, Shimizu S, Yokotani K, Saito M. Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150 [Abstract] [Full Text] [Related]
4. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor. Zeng L, An S, Goetzl EJ. Biochemistry; 1996 Jun 04; 35(22):7159-64. PubMed ID: 8679543 [Abstract] [Full Text] [Related]
5. Roles of the central prostaglandin EP3 receptors in cardiovascular regulation in rats. Ariumi H, Takano Y, Masumi A, Takahashi S, Hirabara Y, Honda K, Saito R, Kamiya HO. Neurosci Lett; 2002 May 10; 324(1):61-4. PubMed ID: 11983295 [Abstract] [Full Text] [Related]
6. EP1-receptor mediation of prostaglandin E2-induced hyperthermia in rats. Oka T, Hori T. Am J Physiol; 1994 Jul 10; 267(1 Pt 2):R289-94. PubMed ID: 7914071 [Abstract] [Full Text] [Related]
7. Biphasic modulation in the trigeminal nociceptive neuronal responses by the intracerebroventricular prostaglandin E2 may be mediated through different EP receptors subtypes in rats. Oka T, Hori T, Hosoi M, Oka K, Abe M, Kubo C. Brain Res; 1997 Oct 17; 771(2):278-84. PubMed ID: 9401748 [Abstract] [Full Text] [Related]
8. Prostaglandin E2 may induce hyperthermia through EP1 receptor in the anterior wall of the third ventricle and neighboring preoptic regions. Oka K, Oka T, Hori T. Brain Res; 1997 Aug 29; 767(1):92-9. PubMed ID: 9365020 [Abstract] [Full Text] [Related]
9. Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype. Molderings G, Malinowska B, Schlicker E. Br J Pharmacol; 1992 Oct 29; 107(2):352-5. PubMed ID: 1330175 [Abstract] [Full Text] [Related]
10. SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL. Tsujisawa T, Inoue H, Nishihara T. J Bone Miner Res; 2005 Jan 29; 20(1):15-22. PubMed ID: 15619665 [Abstract] [Full Text] [Related]
11. Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor. Zeng L, An S, Goetzl EJ. J Biol Chem; 1996 Nov 01; 271(44):27744-50. PubMed ID: 8910368 [Abstract] [Full Text] [Related]
12. Intracerebroventricular injection of prostaglandin E2 increases splenic sympathetic nerve activity in rats. Ando T, Ichijo T, Katafuchi T, Hori T. Am J Physiol; 1995 Sep 01; 269(3 Pt 2):R662-8. PubMed ID: 7573569 [Abstract] [Full Text] [Related]
14. Intracerebroventricular injection of prostaglandin E2 induces thermal hyperalgesia in rats: the possible involvement of EP3 receptors. Oka T, Aou S, Hori T. Brain Res; 1994 Nov 14; 663(2):287-92. PubMed ID: 7874513 [Abstract] [Full Text] [Related]
15. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats. Tang EH, Jensen BL, Skott O, Leung GP, Feletou M, Man RY, Vanhoutte PM. Cardiovasc Res; 2008 Apr 01; 78(1):130-8. PubMed ID: 18093985 [Abstract] [Full Text] [Related]
16. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery. Qian YM, Jones RL, Chan KM, Stock AI, Ho JK. Br J Pharmacol; 1994 Oct 01; 113(2):369-74. PubMed ID: 7834185 [Abstract] [Full Text] [Related]
17. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Meja KK, Barnes PJ, Giembycz MA. Br J Pharmacol; 1997 Sep 01; 122(1):149-57. PubMed ID: 9298541 [Abstract] [Full Text] [Related]
18. Prostaglandin E2 (PGE2) autoamplifies its production through EP1 subtype of PGE receptor in mouse osteoblastic MC3T3-E1 cells. Suda M, Tanaka K, Yasoda A, Natsui K, Sakuma Y, Tanaka I, Ushikubi F, Narumiya S, Nakao K. Calcif Tissue Int; 1998 Apr 01; 62(4):327-31. PubMed ID: 9504958 [Abstract] [Full Text] [Related]
19. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein. Lawrence RA, Jones RL. Br J Pharmacol; 1992 Apr 01; 105(4):817-24. PubMed ID: 1324050 [Abstract] [Full Text] [Related]
20. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice. Minami T, Nishihara I, Uda R, Ito S, Hyodo M, Hayaishi O. Br J Pharmacol; 1994 Jul 01; 112(3):735-40. PubMed ID: 7921597 [Abstract] [Full Text] [Related] Page: [Next] [New Search]